GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Interest Coverage

Biolife Sciences (Biolife Sciences) Interest Coverage : N/A (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Biolife Sciences's Operating Income for the three months ended in May. 2008 was $0.08 Mil. Biolife Sciences's Interest Expense for the three months ended in May. 2008 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Biolife Sciences's Interest Coverage or its related term are showing as below:


BLFE's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 17.5
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Biolife Sciences Interest Coverage Historical Data

The historical data trend for Biolife Sciences's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Biolife Sciences Interest Coverage Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Interest Coverage
No Debt N/A N/A N/A

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Biolife Sciences's Interest Coverage

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolife Sciences's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Interest Coverage falls into.



Biolife Sciences Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biolife Sciences's Interest Coverage for the fiscal year that ended in Nov. 2007 is calculated as

Here, for the fiscal year that ended in Nov. 2007, Biolife Sciences's Interest Expense was $0.00 Mil. Its Operating Income was $0.04 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.21 Mil.

GuruFocus does not calculate Biolife Sciences's interest coverage with the available data.

Biolife Sciences's Interest Coverage for the quarter that ended in May. 2008 is calculated as

Here, for the three months ended in May. 2008, Biolife Sciences's Interest Expense was $0.00 Mil. Its Operating Income was $0.08 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.42 Mil.

GuruFocus does not calculate Biolife Sciences's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Biolife Sciences  (OTCPK:BLFE) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Biolife Sciences Interest Coverage Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020